Sort   by:  
 Page size 
UnknownMicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia.
Not available
S-EPMC5721230 | biostudies-literature
GenomicsWhole Genome and Transcriptome Analysis of Medullary Thyroid Cancer - samples
Sequence data from two medullary thyroid carcinoma patients: WGS datasets generated from tumors and matched normal tissues and RNA-Seq from tumors are included.
EGAD00001001618 | EGA
GenomicsWhole genome and transcriptome analysis of medullary thyroid cancer
Medullary thyroid cancer is the neoplasm of the calcitonin-producing parafollicular cells of the thyroid gland. The hormone calcitonin acts to lower the blood calcium level, counteracting the effects of the parathyroid hormone; it can also serve as a biomarker for the presence or recurrence of medul...
EGAS00001001473 | EGA
GenomicsWhole Genome and Transcriptome Analysis of Anaplastic Thyroid Carcinoma - samples
This dataset includes WGS & WTS alignment data generated from 1 ATC tumor, its matched peripheral blood specimen and 3 authenticated ATC cell lines, THJ-16T, THJ-21T and THJ-29T. In addition, it includes WTS data from extra 4 unique anaplastic cell lines, ACT-1, C643, HTh7 and T238.
EGAD00001001321 | EGA
GenomicsWhole genome and transcriptome analysis of anaplastic thyroid carcinoma
Whole genome and transcriptome analysis of anaplastic thyroid carcinoma
EGAS00001001214 | EGA
GenomicsMEN1 Mutational Analysis in Hurthle Cell Thyroid Carcinoma - samples
This dataset includes 2 pairs of tumour/normal whole genome sequence data as well as MEN1 gene targeted sequencing of an additional 87 specimens.
EGAD00001001085 | EGA
GenomicsWhole genome study of Hurthle cell thyroid carcinoma
Oncocytic thyroid carcinoma, also known as Hürthle cell thyroid carcinoma, accounts for only a small percentage of all thyroid cancers. However, this malignancy often presents at an advanced stage and poses unique challenges to patients and clinicians. Surgical resection of the tumor accompanied in...
EGAS00001000940 | EGA
GenomicsNational Cancer Institute Cancer Genome Characterization Initiative (CGCI)

The Office of Cancer Genomics at the National Cancer Institute is sponsoring a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging sequencing technologies in cancer. The CGCI program includes comprehensive characterization of the genetic a...

phs000235.v3.p1 | EGA
GenomicsMarra_DLBCL_validation - samples
miRNA-seq Cohort of 140 Formalin Fixed Paraffin Embedded Diffuse Large B-cell Lymphoma Patient Samples
EGAD00001001073 | EGA
GenomicsMarra_DLBCL_discovery - samples
miRNA-seq Cohort of 92 Fresh Frozen Diffuse Large B-cell Lymphoma Patient Samples
EGAD00001001074 | EGA
Sort   by:  
 Page size